Corvus Pharmaceuticals Inc.

CRVS | NASDAQ

Price Alert Chart Builder DCF Calculator

$12.42

-$0.14 (-1.11%)

At close: Sep 21, 2026, 4:00 PM ET

$12.42

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-15.28M	-62.29M	-27.03M	-41.31M	-43.24M	-6M
Depreciation & Amortization	105K	85K	151K	367K	460K	632K
Stock-Based Compensation	5.33M	3M	2.15M	2.69M	4.23M	5.75M
Other Working Capital	3.63M	-2.66M	-3.71M	1.08M	-827K	890K
Other Non-Cash Items	-26.53M	35.43M	4.39M	9.81M	5.07M	-37.07M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	3.58M	-1.65M	-3.59M	1.41M	-3.24M	1.91M
Operating Cash Flow	-32.8M	-25.42M	-23.94M	-27.02M	-36.72M	-34.78M
Capital Expenditures	-174K	n/a	-34K	-269K	-5K	-76K
Cash Acquisitions	n/a	5K	n/a	22K	-21.57K	-44.85K
Purchase of Investments	-91.75M	-70.12M	-47.05M	-66.19M	-9.36M	-42.54M
Sales Maturities Of Investments	84.13M	42.63M	62.62M	43.16M	30.92M	87.39M
Other Investing Acitivies	n/a	n/a	n/a	n/a	21.57K	44.85K
Investing Cash Flow	-7.8M	-27.48M	15.54M	-23.28M	21.56M	44.77M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	32.62M	12K	n/a	1.22M	88K
Financial Cash Flow	36.43M	49.03M	7.86M	n/a	62.16M	1.31M
Net Cash Flow	-4.16M	-3.88M	-539K	-50.3M	47M	11.3M
Free Cash Flow	-32.97M	-25.42M	-23.97M	-27.29M	-36.72M	-34.85M
Adj. Free Cash Flow	-38.3M	-28.43M	-26.12M	-29.98M	-40.95M	-40.6M
Maintenance CapEx	-105K	n/a	-34K	-269K	-5K	-76K
Growth CapEx	-69K	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-32.9M	-25.42M	-23.97M	-27.29M	-36.72M	-34.85M